Agenda: Eighth Joint Sectoral Group (JSG) meeting of the Protocol to the Comprehensive Economic and Trade Agreement (CETA) between the European Union and Canada on the mutual recognition of the compliance and enforcement programs regarding Good Manufacturing Practices (GMP) for pharmaceutical products
May 26, 2026 (by videoconference)
Agenda
- Welcoming remarks
- Adoption of the agenda
- Inclusion of active pharmaceutical ingredients (API) in the operational scope of the CETA protocol for pharmaceuticals
- State of play of the recognition of European Union (EU) national competent authorities by Health Canada
- Updates from Health Canada, the European Medicines Agency, and the European Commission
- Follow-up actions and any other business
- Date modified:
